Trade Ideas

Actionable trade ideas with defined risk and time horizons.

Curated trade ideas across equities, options, and other instruments, featuring clear directional bias, time horizon, and risk considerations. Trade ideas are designed to align market context, technical structure, and risk management principles.

Articles

4,803 total articles

FactSet: Quality Cash Flows, Cheap Multiple - A Tactical Long

FactSet: Quality Cash Flows, Cheap Multiple - A Tactical Long

FactSet (FDS) looks oversold relative to its subscription-style revenue, high ROE, and healthy free cash flow. The market is punishing legacy providers on AI fears and macro uncertainty; that creates a tactical opportunity to buy FactSet at reasonable multiples. Trade plan: enter $217.00, stop $200.00, target $275.00 over the next 45 trading days.

MDU: Regulated Growth + Capital Spend Makes a Quiet Long Here

MDU: Regulated Growth + Capital Spend Makes a Quiet Long Here

MDU Resources offers a low-volatility way to play utility rate-base growth and midstream expansion. With a $3.1 billion capital plan through 2030, 16% reported rate base growth and steady dividends, the setup favors a controlled long trade around $21.70 with a mid-term target of $23.50 and a stop at $20.50.

Why AI-First Google Finance Makes Alphabet a Compelling Long Trade

Why AI-First Google Finance Makes Alphabet a Compelling Long Trade

Alphabet's move to embed advanced Gemini LLMs into Google Finance creates a high-engagement, high-monetization product that plays to the company's ad moat, cloud infrastructure, and custom TPU roadmap. With a market cap near $3.9 trillion, robust free cash flow of $73.3B and healthy fundamentals, the risk/reward now favors a calibrated long positio…

NextEra Energy: Iran Shock Re-weights The Energy Trade Toward Renewables

NextEra Energy: Iran Shock Re-weights The Energy Trade Toward Renewables

Geopolitical disruption in the Middle East has exposed the fragility of fossil-fuel supply chains and uplifted the relative investment case for large-scale renewables and regulated utilities. NextEra Energy's scale in wind, solar and regulated Florida operations, plus a healthy free cash flow profile and modest dividend yield, make it a pragmatic s…

Buy Kymera (KYMR): KT-621 Momentum and a Clear Clinical Path to Re-rate

Buy Kymera (KYMR): KT-621 Momentum and a Clear Clinical Path to Re-rate

Kymera’s oral STAT6 degrader KT-621 is the company’s highest-conviction asset. With Phase 2b BROADEN2 dosing underway in atopic dermatitis, an asthma Phase 2b planned for early 2026 and $1.6 billion in cash, the stock is positioned for a clinical-driven re-rate. We lay out an actionable trade with entry, stop and target and a balanced risk framewor…

Coca-Cola: A Reliable Retirement Core With Room to Ride

Coca-Cola: A Reliable Retirement Core With Room to Ride

Coca-Cola blends steady dividend income with durable cash flow and pricing power. At roughly $326.7B market cap and a 2.66% yield, the stock is positioned as a retirement-friendly core holding. This trade idea lays out an actionable long-term (180 trading days) buy with concrete entry, stop and target levels while flagging valuation and debt as pri…

Plains All American: Cash Flow, Yield and a Clear Path to Value Creation

Plains All American: Cash Flow, Yield and a Clear Path to Value Creation

Plains All American (PAA) combines a defensive, fee-based midstream footprint with unusually strong free cash flow and a sizable distribution yield. With Q1 earnings on 05/08/2026, a pending NGL transaction that could boost parent earnings, and FCF of $2.27B against a $15.3B market cap, PAA looks like a beaten-up growth-yield hybrid ready for a re-…

Rumble: An Overlooked Entry into GPU-Backed AI Cloud

Rumble: An Overlooked Entry into GPU-Backed AI Cloud

Rumble (RUM) is transitioning from a niche video platform to an AI cloud and creator-economy play after signing up a planned combination with Northern Data and a GPU services deal with Tether. The shares trade near the low end of their 52-week range despite material upside if integration and monetization work. This trade idea lays out an actionable…

Buy the Dip in Novo Nordisk: Valuation, Buybacks and a Clear Path Back Up

Buy the Dip in Novo Nordisk: Valuation, Buybacks and a Clear Path Back Up

Novo Nordisk shares have been punished on competitive headlines and a sector rotation, but the stock trades at ~11x P/E with a 3.3% dividend yield, a modest buyback and accelerating pricing programs for Wegovy. This trade idea recommends buying the dip at $37.45 with a $50.00 target over 180 trading days and a $33.50 protective stop — a risk/reward…